All In Biotech

Drug Trial Radar · NCT05047263

A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Phase 3 Study to Investigate the Efficacy and Safety of FInerenone, in Addition to Standard of Care, on the Progression of Kidney Disease in Patients With Non-Diabetic Chronic Kidney Disease

Last checked: Nov 20, 2026Latest source record: Feb 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,584 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,584

Actual

Start

Sep 21, 2021

Primary completion

Dec 31, 2025

Study completion Feb 2, 2026

Sponsor

Lead sponsor
BayerBayer (BAYRY)
Sponsor type
Industry
First posted
Sep 17, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial treatment, finerenone, is being developed to help people who have long lasting kidney disease, also known as chronic kidney disease (CKD). It works by blocking a certain hormone called aldosterone that causes injury and inflammation in the heart and kidney which is known to play a role in CKD. In this trial, the researchers want to learn if finerenone helps to slow down the worsening of the participants' non-diabetic CKD compared to a placebo. A placebo looks like a trial treatment but does not have any medicine in it. The trial will include about 1,580 men and women who are at least 18 years old. The participants will take finerenone or a placebo once a day as tablets by mouth. All of the participants will also continue to take their current medicine for their CKD. The participants will be in the trial for up to about 50 months. During the trial, the doctors will collect blood and urine samples and check the participants' health. The participants will also answer questions about how they are feeling and what adverse events they are having. An adverse event is a medical problem that happens during the trial. Doctors keep track of all adverse events that happen in trials, even if they do not think the adverse events might be related to the trial treatments.

Conditions

  • Non-diabetic Chronic Kidney Disease

Interventions

  • Finerenone (BAY94-8862)Drug

    Tablet, 10 mg or 20 mg, once daily (OD), oral

  • PlaceboDrug

    Tablet, once daily, oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean rate of change as measured by the total slope of eGFR from baseline to Month-32.Time frame: From baseline to month 32

Locations

326 sites in 24 countries. Site status is shown where the registry gives one.

  • Nephrology Consultants, LLC

    Huntsville, Alabama

  • Balboa Research SMO+ - Chula Vista - West

    Chula Vista, California

  • Balboa Research SMO+ - El Centro

    El Centro, California

  • UCLA Clinical and Translational Research Center - Nephrology

    Los Angeles, California

  • Balboa Nephrology Medical Group - Poway

    Poway, California

  • North America Research Institute - San Dimas

    San Dimas, California

  • United Clinical Research & Innovations

    South Gate, California

  • University of Colorado | Renal Research Office

    Aurora, Colorado

  • DaVita Clinical Research | Middlebury, CT

    Middlebury, Connecticut

  • Yale University | Nephrology Clinical Research

    New Haven, Connecticut

  • Chase Medical Research, LLC

    Waterbury, Connecticut

  • Research Physicians Network Alliance

    Boca Raton, Florida

  • Florida Kidney Physicians - Boca Raton

    Boca Raton, Florida

  • AdventHealth Translational Research Institute

    Orlando, Florida

  • Grady Memorial Hospital - Endocrinology

    Atlanta, Georgia

  • Southeastern Clinical Research Institute, LLC

    Augusta, Georgia

  • Central Georgia Kidney Specialists - Macon

    Macon, Georgia

  • Frenova Renal Research | Boise Kidney and Hypertension

    Meridian, Idaho

  • Northwestern Medicine - Feinberg School of Medicine - Nephrology and Hypertension

    Chicago, Illinois

  • Research by Design, LLC | Chicago, IL

    Chicago, Illinois

  • Nephrology Associates of Northern Illinois and Indiana - Hinsdale

    Hinsdale, Illinois

  • University of Iowa Health Care Medical Center - Cardiology

    Iowa City, Iowa

  • KUMC Clinical and Translational Science Unit - Nephrology

    Kansas City, Kansas

  • Kansas Nephrology Research Institute

    Wichita, Kansas

  • Wichita Nephrology Group, PA

    Wichita, Kansas

  • Northwest Louisiana Nephrology - Shreveport - 1800 Buckner St.

    Shreveport, Louisiana

  • Johns Hopkins Hospital - Nephrology

    Baltimore, Maryland

  • Tufts Medical Center | Nephrology Department

    Boston, Massachusetts

  • DaVita Clinical Research | Edina, MN

    Edina, Minnesota

  • University Hospital - UMMC - Nephrology

    Jackson, Mississippi

  • Clinical Research Consultants, a JCCT Company

    Kansas City, Missouri

  • St. Louis Heart and Vascular, PC - Christian Hospital Office

    St Louis, Missouri

  • UNM Clinical and Translational Science Center - Nephrology

    Albuquerque, New Mexico

  • Mountain Kidney & Hypertension Associates

    Asheville, North Carolina

  • UNC Hospitals Outpatient Center at Eastowne - Nephrology

    Chapel Hill, North Carolina

  • East Carolina University | Nephrology & Hypertension

    Greenville, North Carolina

  • Eastern Nephrology Associates | Wilmington

    Wilmington, North Carolina

  • UH Cleveland Medical Center - Nephrology

    Cleveland, Ohio

  • Cleveland Clinic | Urological and Kidney Department

    Cleveland, Ohio

  • Northeast Clinical Research Center | Bethlehem, PA

    Bethlehem, Pennsylvania

Showing 40 of 326 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.